Richard Mailman

Professor and College of Medicine Distinguished Senior Scholar

Richard Mailman

Publication Tags

These publication tags are generated from the output of this researcher. Click any tag below to view other Huck researchers working on the same topic.

Parkinson Disease Dopamine Agonists Short Term Memory Therapeutics Pharmacology Dopamine Hydroxymethylglutaryl Coa Reductase Inhibitors Schizophrenia Arrestin Prefrontal Cortex Dopamine D1 Receptors Pharmaceutical Preparations Pars Compacta Dihydrexidine Methylphenidate Ligands Genes Odds Ratio Red Nucleus Neurons Substantia Nigra Neurophysiology Modafinil Mesencephalon Proteins

Most Recent Publications

Resting-state global brain activity affects early β-amyloid accumulation in default mode network

Feng Han, Xufu Liu, Richard B. Mailman, Xuemei Huang, Xiao Liu, 2023, Nature Communications

A noncommutative combinatorial protein logic circuit controls cell orientation in nanoenvironments

Jiaxing Chen, Yashavantha L. Vishweshwaraiah, Richard B. Mailman, Erdem D. Tabdanov, Nikolay V. Dokholyan, 2023, Science advances

Higher hippocampal diffusivity values in welders are associated with greater R2* in the red nucleus and lower psychomotor performance

Eun Young Lee, Juhee Kim, Janina Manzieri Prado-Rico, Guangwei Du, Mechelle Lewis, Lan Kong, et al., Byoung Gwon Kim, Young Seoub Hong, Jeff D. Yanosky, Richard B. Mailman, Xuemei Huang, 2023, NeuroToxicology on p. 53-68

Effects of Toxic Metals on Neurotransmitters

Richard B. Mailman, Mechelle Mayleben, Cindy P. Lawler, 2023, on p. 627-638

Student Perceptions of a New Course Using Argumentation in Medical Education

Andrew J. Foy, Kent Vrana, Paul Haidet, Bernice L. Hausman, Nancy E. Adams, Ira Ropson, Daniel R. Wolpaw, David Rabago, Richard B. Mailman, Xuemei Huang, 2023, Advances in Medical Education and Practice on p. 989-998

Characterization of behavioral changes in T-maze alternation from dopamine D<sub>1</sub> agonists with different receptor coupling mechanisms

Jack X. Cimino, Mi Zhou, James Waxmonsky, Richard Mailman, Yang Yang, 2023, Psychopharmacology

Dopamine D<sub>1</sub> Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease

Mechelle Lewis, Lauren J. Van Scoy, Sol De Jesus, Jonathan G. Hakun, Paul Eslinger, Julio Fernandez-Mendoza, L Kong, Yang Yang, Bethany Snyder, Natalia Loktionova, Sridhar Duvvuri, David Gray, Xuemei Huang, Richard B. Mailman, 2023, Biomolecules on p. 829

A Dopamine D<sub>1</sub> Agonist Versus Methylphenidate in Modulating Prefrontal Cortical Working Memory

Yang Yang, Mechelle Lewis, Lan Kong, Richard B. Mailman, 2022, Journal of Pharmacology and Experimental Therapeutics on p. 88-89

Dopamine D<sub>1</sub> receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior, and neurophysiology

Yang Yang, Mechelle Lewis, Xuemei Huang, Nikolay V. Dokholyan, Richard Mailman, 2022, International Journal of Biochemistry

Dose-Dependent Regulation on Prefrontal Neuronal Working Memory by Dopamine D<sub>1</sub> Agonists: Evidence of Receptor Functional Selectivity-Related Mechanisms

Yang Yang, Susan D. Kocher, Mechelle Lewis, Richard B. Mailman, 2022, Frontiers in Neuroscience

Most-Cited Papers

Quantitative susceptibility mapping of the midbrain in Parkinson's disease

Guangwei Du, T Liu, Mechelle M. Lewis, Lan Kong, Y Wang, James Connor, Richard B. Mailman, Xuemei Huang, 2016, Movement Disorders on p. 317-324

Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia

Amy F.T. Arnsten, Ragy R. Girgis, David L. Gray, Richard B. Mailman, 2017, Biological Psychiatry on p. 67-77

Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study

Xuemei Huang, Alvaro Alonso, Xuguang Guo, David M. Umbach, Maya L. Lichtenstein, Christie M. Ballantyne, Richard B. Mailman, Thomas H. Mosley, Honglei Chen, 2015, Movement Disorders on p. 552-559

Projection of the prevalence of Parkinson's disease in the coming decades: Revisited

Alexander Rossi, Kristin Berger, Honglei Chen, Douglas Leslie, Richard Mailman, Xuemei Huang, 2018, Movement Disorders on p. 156-159

Effects of the D<sub>1</sub> dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder

Daniel R. Rosell, Lauren C. Zaluda, Margaret M. McClure, M. Mercedes Perez-Rodriguez, K. Sloan Strike, Deanna M. Barch, Philip D. Harvey, Ragy R. Girgis, Erin A. Hazlett, Richard B. Mailman, Anissa Abi-Dargham, Jeffrey A. Lieberman, Larry J. Siever, 2015, Neuropsychopharmacology on p. 446-453

Transcriptional repression by the BRG1-SWI/SNF complex affects the pluripotency of human embryonic stem cells

Xiaoli Zhang, Bing Li, Wenguo Li, Lijuan Ma, Dongyan Zheng, Leping Li, Weijing Yang, Min Chu, Wei Chen, Richard B. Mailman, Jun Zhu, Guoping Fan, Trevor K. Archer, Yuan Wang, 2014, Stem Cell Reports on p. 460-474

Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients

Guangwei Du, Mechelle Lewis, Christopher Sica, L He, James Connor, Lan Kong, Richard Mailman, Xuemei Huang, 2018, Movement Disorders on p. 1423-1431

Cancer and the dopamine D<sub>2</sub> receptor: A pharmacological perspective

Jillian S. Weissenrieder, Jeffrey D. Neighbors, Richard B. Mailman, Raymond J. Hohl, 2019, Journal of Pharmacology and Experimental Therapeutics on p. 111-126

Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database

Guodong Liu, N Sterling, Lan Kong, Mechelle M. Lewis, Richard B. Mailman, H Chen, Douglas Leslie, Xuemei Huang, 2017, Movement Disorders on p. 913-917

Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor

Michelle G. Baladi, Michael J. Forster, Michael B. Gatch, Richard Mailman, Danielle L. Hyman, Lawrence P. Carter, Aaron Janowsky, 2018, Journal of Pharmacology and Experimental Therapeutics on p. 367-376